Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin.
This study has been terminated.
Study NCT00049959 Information provided by QLT Inc
First Received: November 15, 2002 Last Updated: July 28, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Basal Cell Carcinoma
Gorlin Syndrome
Additional conditions recognized in this trial
Basal Cell Nevus Syndrome
Carcinoma
Carcinoma, Basal Cell
Syndrome
More general conditions related to this trial
Abnormalities, Multiple
Bone Cysts
Bone Diseases
Bone Diseases, Developmental
Congenital Abnormalities
Cysts
Disease
Genetic Diseases, Inborn
Jaw Cysts
Jaw Diseases
Musculoskeletal Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Basal Cell
Neoplasms, Glandular and Epithelial
Neoplastic Syndromes, Hereditary
Odontogenic Cysts
Pathologic Processes
Stomatognathic Diseases
Interventions listed in this trial
verteporfin PDT
Additional drug interventions recognized in this trial
Verteporfin
More general drug interventions related to this trial
Dermatologic Agents
Pharmacologic Actions
Photosensitizing Agents
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
QLT Inc
Novartis
Back to top of Main Content
